Area of research
Psychiatry and Mental health · Pharmacology
Research interest
Research focused on Bipolar disorder and Randomized controlled trial, with related work in Task force, Pharmacogenomics, Major depressive disorder. Notable publications include 'Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study', 'Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer’s disease: A meta-analysis of in vivo magnetic resonance...', and 'A report on older‐age bipolar disorder from the International Society for Bipolar Disorders Task Force'.
Physical comorbidities of older age bipolar disorder (OABD) patients: A global replication analysis of prevalence and sex differences
Sex Differences Among Older Adults With Bipolar Disorder: Results From the Global Aging & Geriatric Experiments in Bipolar Disorder (GAGE-BD) Project
Effects of lithium on serum Brain‐Derived Neurotrophic Factor in Alzheimer’s patients with agitation
Cognition in older adults with bipolar disorder: An ISBD task force systematic review and meta‐analysis based on a comprehensive neuropsychological assessment
Predictors of functional impairment in bipolar disorder: Results from 13 cohorts from seven countries by the global bipolar cohort collaborative
Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer’s disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies
Bipolar symptoms, somatic burden, and functioning in older‐age bipolar disorder: Analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project
Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorder
Electroconvulsive Therapy Practice Changes in Older Individuals Due to COVID-19: Expert Consensus Statement
Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression
Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial
The Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE‐BD) project: Understanding older‐age bipolar disorder by combining multiple datasets
Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial
Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design
Brain and Biological Markers of Aging in Late-Life Mood Disorders: Implications for Understanding and Treating Geriatric Depression and Bipolar Disorder
Electroconvulsive therapy (ECT) for treating agitation in dementia (major neurocognitive disorder) – a promising option
Demographic and Clinical Profile of Patients With Dementia Receiving Electroconvulsive Therapy
A report on older‐age bipolar disorder from the International Society for Bipolar Disorders Task Force
Clinical Characteristics of Patients with Late Life Bipolar Disorder in the Community: Data from the NNDC Registry
Long-Term Outcomes of a Randomized Trial of Integrated Skills Training and Preventive Healthcare for Older Adults with Serious Mental Illness
Tissue-Specific Differences in Brain Phosphodiesters in Late-Life Major Depression
Coenzyme Q10 Effects on Creatine Kinase Activity and Mood in Geriatric Bipolar Depression